Biogen, Inc. (BIIB)
$272.88
4.38 (1.58%)
19:58 EST
BIIB Stock Quote Delayed 30 Minutes
Previous Close
-
Market Cap
57.58B
PE Ratio
19.49
EPS
14
Volume (Avg. Vol.)
1.54M
Day's Range
269.31 - 278.92
52-Week Range
223.25 - 363.92
Dividend & Yield
N/A (N/A)
BIIB Stock Predictions, Articles, and Biogen, Inc. News
- From InvestorPlace
- From the Web
7 Stocks to Sell for March
The market is starting to get volatile again and sector rotation is underway. Clear the decks by dumping these stocks to sell for March.
14 AI Stocks to Stay Away From
Whether in transportation, manufacturing or healthcare, don't touch any of these 14 AI-related stocks with a 10-foot pole. Here's why.
The 7 Best Coronavirus Vaccine Stocks Still In The Race For A Cure
Buying strong vaccine stocks at the forefront of the scientific race to treat Covid-19 will help any long-term portfolio in 2021.
3 Under-Loved Biotech Stocks to Buy for Profits Into 2021
Biotech stocks are vulnerable to headlines, but these three have too much potential to ignore. Own them for a swing trade into 2021.
4 Top Stock Trades for Thursday: BIIB, PTON, GM, WEN
Biogen, Peloton, General Motors and Wendy's were our top stock trades for Thursday. Now, let's look at the charts to see what's going on.
The 8 Best Stocks in Warren Buffett’s Pocket Right Now
Warren Buffett stocks perhaps aren't what they once were. But these 8 names, including AAPL stock, look like the best of the Berkshire portfolio.
Biogen Earnings: BIIB Stock Jumps 1% Higher on Q2 Beats
Biogen earnings on Wednesday have BIIB stock higher after the company crushed Wall Street's expectations for EPS and revenue for the quarter.
Potential Alzheimer’s Drug Not Enough to Excite Biogen Stock Investors
Biogen opened higher by around 10% on news of its Alzheimer's drug. By the end of day, BIIB stock gave up a bulk of its gains. What gives?
4 Top Stock Trades for Thursday: TWTR, NIO, BIIB, SNAP
Snap, Nio, Biogen and Twitter were our top stock trades for Thursday. That said, let's see how the charts are setting up after some big moves.
Biogen News: BIIB Stock Battered 7% by MS Drug Patent Ruling
Biogen (BIIB) news for Thursday concerning a lost court ruling surrounding its multiple sclerosis drug has BIIB stock taking a beating.
As Biogen Stock Struggles, Look Elsewhere for Biotech Exposure
Biogen has solid and consistent revenue, profit and cash flow. But Biogen stock has a low valuation because it has no growth.
7 of the Best Blue-Chip Stocks to Buy
Investors need to differentiate between speculative stocks rising higher than ever and proven blue-chip stocks, and stick to the latter.
7 Top-Rated Biotech Stocks to Buy on the Hunt for a Vaccine
Biotech stocks are in the spotlight in 2020, with the race to develop testing, treatment and a vaccine for Covid-19 driving rapid growth.
Nothing Will Stop Biogen Stock From Moving Higher
The Alzheimer's-drug delay disappointed Biogen stock owners, but the long-term outlook for the company remains solid.
10 Stocks to Buy for an Aging Population
Aging seniors have been put firmly in the crosshairs of the novel coronavirus. These 10 stocks to buy will benefit from this brutal reality.
3 Mega Cap Stocks Earnings Dips to Buy
Investors are often wrong about how they trade mega cap stocks on their earnings headline. This created opportunities in INTC, IBM and BIIB.
3 Big Stock Charts for Thursday: Snap, Biogen, and L Brands
Thursday's big stock charts feature names that released noteworthy earnings data.
3 Big Stock Charts for Thursday: Goldman Sachs, FedEx, and Biogen
Thursday's big stock charts feature names that outperformed during a major market surge.
3 Big Stock Charts for Tuesday: Biogen, Activision Blizzard, and Plug Power
Tuesday's big stock charts feature stocks holding support whose businesses could, and maybe should, hold up in the near term.
7 Biotech Stocks to Buy and Hold in 2020
Biotech stocks pulled off an impressive rally to finish 2019 strong. These names in the industry are looking to do the same in 2020.

Navellier Ratings
Powered by Portfolio GraderTotal Grade
F
Strong Sell